Coherus BioSciences Announces New Employment Inducement Grants
July 21 2023 - 5:30PM
Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq:
CHRS), today announced that effective July 20, 2023, the
compensation committee of the Company’s board of directors granted
options to purchase an aggregate of 187,000 shares of the common
stock of the Company to newly hired employees with a per share
exercise price of $4.17, the closing trading price on the grant
date. One Senior Vice President level executive was granted options
to purchase 100,000 shares; and five additional non-officer
employees were granted options to purchase an aggregate of 87,000
shares.
The stock options were granted pursuant to the Coherus
BioSciences, Inc. 2016 Employment Commencement Incentive Plan,
which was approved by the Company’s board of directors in June 2016
under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity
grants to induce new employees to enter into employment with the
Company.
Coherus BioSciences Contact Information:
IR ContactMarek CiszewskiCoherus BioSciences,
Inc.IR@coherus.com
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Jul 2023 to Jul 2024